{
  "Variants Include": [
    {
      "Gene": "PARK2",
      "variants": [
        {
          "HGVS": "NM_000931.1:c.437G>A",
          "cDNA Change": {
            "transcript": "NM_000931.1",
            "ref": "G",
            "alt": "A",
            "position": "437"
          },
          "Protein Change": {
            "ref": "R",
            "alt": "Q",
            "position": "146"
          },
          "Description in input context": "p.R146Q variant"
        },
        {
          "HGVS": "NM_000931.1:c.437G>T",
          "cDNA Change": {
            "transcript": "NM_000931.1",
            "ref": "G",
            "alt": "T",
            "position": "437"
          },
          "Protein Change": {
            "ref": "R",
            "alt": "W",
            "position": "146"
          },
          "Description in input context": "p.R146W variant"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's disease",
    "MONDO": "MONDO:0005243"
  },
  "Experiment Method": [
    {
      "Assay Method": "Western Blot",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "HEK293",
        "Description": "HEK293 cells overexpressing PARK2 variants (p.R146Q, p.R146W) were used."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_000931.1:c.437G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "partial loss-of-function",
          "Result Description": "Protein expression levels reduced by 60% compared to wild-type."
        },
        {
          "Variant": "NM_000931.1:c.437G>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "partial loss-of-function",
          "Result Description": "Protein expression levels reduced by 55% compared to wild-type."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Three biological replicates were performed."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each sample was run in triplicate."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type PARK2 cDNA was used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Empty vector was used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "2"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "No",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "ANOVA was used for statistical analysis."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Protein expression ≥ 80% of wild-type levels.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Protein expression < 60% of wild-type levels.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Immunoprecipitation",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "HEK293",
        "Description": "HEK293 cells expressing PARK2 variants were used for IP experiments."
      },
      "Readout type": "Qualitative",
      "Readout description": [
        {
          "Variant": "NM_000931.1:c.437G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "intermediate effect",
          "Result Description": "Reduced interaction with parkin E3 ligase domain."
        },
        {
          "Variant": "NM_000931.1:c.437G>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "intermediate effect",
          "Result Description": "Reduced interaction with parkin E3 ligase domain."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Two biological replicates were performed."
      },
      "Technical replicates": {
        "Technical replicates": "No",
        "Description": "N.D."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type PARK2 was used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Non-specific IgG was used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "1"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "No",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "Student's t-test was used for comparison."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Interaction signal ≥ 50% of wild-type levels.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Interaction signal < 30% of wild-type levels.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Mass Spectrometry",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "HEK293",
        "Description": "HEK293 cells expressing PARK2 variants were analyzed by MS."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_000931.1:c.437G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "partial loss-of-function",
          "Result Description": "Reduced ubiquitination efficiency of parkin substrates."
        },
        {
          "Variant": "NM_000931.1:c.437G>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "partial loss-of-function",
          "Result Description": "Reduced ubiquitination efficiency of parkin substrates."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Three biological replicates were performed."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each sample was analyzed in duplicate."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type PARK2 was used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Non-specific ubiquitin was used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "2"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "No",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "ANOVA was used for statistical analysis."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Ubiquitination efficiency ≥ 70% of wild-type levels.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Ubiquitination efficiency < 40% of wild-type levels.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Cell Viability Assay",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "SH-SY5Y",
        "Description": "SH-SY5Y cells expressing PARK2 variants were used for viability assays."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_000931.1:c.437G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "partial loss-of-function",
          "Result Description": "Cell viability reduced by 45% compared to wild-type."
        },
        {
          "Variant": "NM_000931.1:c.437G>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "partial loss-of-function",
          "Result Description": "Cell viability reduced by 50% compared to wild-type."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Three biological replicates were performed."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each sample was run in triplicate."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type PARK2 was used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Non-specific siRNA was used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "2"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "No",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "Student's t-test was used for comparison."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Cell viability ≥ 85% of wild-type levels.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Cell viability < 60% of wild-type levels.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}